Drug Profile
Research programme: anti-microbials - Synovo
Alternative Names: MDR-PhageLatest Information Update: 28 Mar 2022
Price :
$50
*
At a glance
- Originator Synovo
- Class Anti-infectives; Antibacterials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Respiratory tract infections
Most Recent Events
- 28 Mar 2022 No recent reports of development identified for research development in Respiratory-tract-infections in Germany